Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 215

1.

Guideline-based antibiotics and mortality in healthcare-associated pneumonia.

Madaras-Kelly KJ, Remington RE, Sloan KL, Fan VS.

J Gen Intern Med. 2012 Jul;27(7):845-52. doi: 10.1007/s11606-012-2011-y. Epub 2012 Mar 7.

2.

Guideline-concordant therapy and outcomes in healthcare-associated pneumonia.

Attridge RT, Frei CR, Restrepo MI, Lawson KA, Ryan L, Pugh MJ, Anzueto A, Mortensen EM.

Eur Respir J. 2011 Oct;38(4):878-87. doi: 10.1183/09031936.00141110. Epub 2011 Mar 24.

3.
4.

Impact of guideline-consistent therapy on outcome of patients with healthcare-associated and community-acquired pneumonia.

Grenier C, Pépin J, Nault V, Howson J, Fournier X, Poirier MS, Cabana J, Craig C, Beaudoin M, Valiquette L.

J Antimicrob Chemother. 2011 Jul;66(7):1617-24. doi: 10.1093/jac/dkr176. Epub 2011 May 17.

5.

Predicting antibiotic resistance to community-acquired pneumonia antibiotics in culture-positive patients with healthcare-associated pneumonia.

Madaras-Kelly KJ, Remington RE, Fan VS, Sloan KL.

J Hosp Med. 2012 Mar;7(3):195-202. doi: 10.1002/jhm.942. Epub 2011 Oct 28.

PMID:
22038859
6.
7.

Epidemiology, antibiotic therapy, and clinical outcomes in health care-associated pneumonia: a UK cohort study.

Chalmers JD, Taylor JK, Singanayagam A, Fleming GB, Akram AR, Mandal P, Choudhury G, Hill AT.

Clin Infect Dis. 2011 Jul 15;53(2):107-13. doi: 10.1093/cid/cir274.

8.

Health care-associated pneumonia and community-acquired pneumonia: a single-center experience.

Micek ST, Kollef KE, Reichley RM, Roubinian N, Kollef MH.

Antimicrob Agents Chemother. 2007 Oct;51(10):3568-73. Epub 2007 Aug 6.

9.

A new strategy for healthcare-associated pneumonia: a 2-year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial empiric therapy.

Maruyama T, Fujisawa T, Okuno M, Toyoshima H, Tsutsui K, Maeda H, Yuda H, Yoshida M, Kobayashi H, Taguchi O, Gabazza EC, Takei Y, Miyashita N, Ihara T, Brito V, Niederman MS.

Clin Infect Dis. 2013 Nov;57(10):1373-83. doi: 10.1093/cid/cit571. Epub 2013 Sep 2.

10.

Pneumonia treated in the internal medicine department: focus on healthcare-associated pneumonia.

Giannella M, Pinilla B, Capdevila JA, Martínez Alarcón J, Muñoz P, López Álvarez J, Bouza E; Estudio de Neumonía En Medicina Interna study Group from the Sociedad Española de Medicina Interna.

Clin Microbiol Infect. 2012 Aug;18(8):786-94. doi: 10.1111/j.1469-0691.2011.03757.x. Epub 2012 Jan 27.

11.

One-year outcomes of community-acquired and healthcare-associated pneumonia in the Veterans Affairs Healthcare System.

Hsu JL, Siroka AM, Smith MW, Holodniy M, Meduri GU.

Int J Infect Dis. 2011 Jun;15(6):e382-7. doi: 10.1016/j.ijid.2011.02.002. Epub 2011 Mar 9.

12.

Clinical impact of broad-spectrum empirical antibiotic therapy in patients with healthcare-associated pneumonia: a multicenter interventional study.

Falcone M, Corrao S, Licata G, Serra P, Venditti M.

Intern Emerg Med. 2012 Dec;7(6):523-31. doi: 10.1007/s11739-012-0795-8. Epub 2012 Jun 12.

PMID:
22688529
13.

Epidemiology and predictors of multidrug-resistant community-acquired and health care-associated pneumonia.

Gross AE, Van Schooneveld TC, Olsen KM, Rupp ME, Bui TH, Forsung E, Kalil AC.

Antimicrob Agents Chemother. 2014 Sep;58(9):5262-8. doi: 10.1128/AAC.02582-14. Epub 2014 Jun 23.

14.

Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit.

Frei CR, Attridge RT, Mortensen EM, Restrepo MI, Yu Y, Oramasionwu CU, Ruiz JL, Burgess DS.

Clin Ther. 2010 Feb;32(2):293-9. doi: 10.1016/j.clinthera.2010.02.006.

PMID:
20206787
15.

Timing of antibiotic administration and outcomes of hospitalized patients with community-acquired and healthcare-associated pneumonia.

Simonetti A, Viasus D, Garcia-Vidal C, Adamuz J, Roset A, Manresa F, Dorca J, Gudiol F, Carratalà J.

Clin Microbiol Infect. 2012 Nov;18(11):1149-55. doi: 10.1111/j.1469-0691.2011.03709.x. Epub 2011 Nov 24.

16.

The difference in clinical presentations between healthcare-associated and community-acquired pneumonia in university-affiliated hospital in Korea.

Jeon EJ, Cho SG, Shin JW, Kim JY, Park IW, Choi BW, Choi JC.

Yonsei Med J. 2011 Mar;52(2):282-7. doi: 10.3349/ymj.2011.52.2.282.

17.

Community-acquired pneumonia with risk for drug-resistant pathogens.

Fleming V, Buck B, Nix N, Kumar P, Southwood R.

South Med J. 2013 Mar;106(3):209-16. doi: 10.1097/SMJ.0b013e318287fe71.

PMID:
23462490
18.

Healthcare-associated pneumonia: diagnostic criteria and distinction from community-acquired pneumonia.

Falcone M, Venditti M, Shindo Y, Kollef MH.

Int J Infect Dis. 2011 Aug;15(8):e545-50. doi: 10.1016/j.ijid.2011.04.005. Epub 2011 May 26. Review.

19.

Clinical and economic outcomes for patients with health care-associated Staphylococcus aureus pneumonia.

Shorr AF, Haque N, Taneja C, Zervos M, Lamerato L, Kothari S, Zilber S, Donabedian S, Perri MB, Spalding J, Oster G.

J Clin Microbiol. 2010 Sep;48(9):3258-62. doi: 10.1128/JCM.02529-09. Epub 2010 Jul 14.

20.

Antimicrobial drug-resistant microbes associated with hospitalized community-acquired and healthcare-associated pneumonia: a multi-center study in Taiwan.

Wu CL, Ku SC, Yang KY, Fang WF, Tu CY, Chen CW, Hsu KH, Fan WC, Lin MC, Chen W, Ou CY, Yu CJ.

J Formos Med Assoc. 2013 Jan;112(1):31-40. doi: 10.1016/j.jfma.2011.09.028. Epub 2012 Jun 7.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk